Pharma and biology researchers developing the next generation of therapeutics can now take advantage of NVIDIA BioNeMo’s expanded generative AI toolkit, along with new ways to access its models. The latest BioNeMo foundation models can analyze DNA sequences, predict how proteins will change shape in response to a drug molecule, and determine a cell’s function
Read Article
Comments
Post a Comment